The Definitive Report on the Worldwide Legal Cannabis Industry

This is another way The Arcview Advantage™ gives pioneers in the cannabis industry, investors, and companies the dealmaking edge. Get the latest industry data to drive your decisions.

Published on April 2020

GET NOW

Produced in partnership with

THE Definitive Report on the Worldwide Legal Cannabis Industry

Newly released: The 8th edition of The State of Legal Cannabis Markets helps you navigate the ever evolving cannabis industry.

This is another way The Arcview Advantage™ gives pioneers in the cannabis industry, investors, and companies the dealmaking edge. Get the latest industry data to drive your decisions.

ORDER NOW

Produced in partnership with

A Must-Have for Investors and Operators

Digital access to the 140+ page report
250+ data-rich graphs, charts and tables
Downloadable slides of select charts for your presentations

GET NOW

Worldwide legal cannabis industry revenue is forecast to grow another 38% to $20.4 billion in 2020, and sales are forecast to reach $46.8 billion in 2025, growing at a 21.2% CAGR 2019-2025.

In 2019, U.S. legal cannabis spending increased 36.5% to $12.4 billion. The report addresses several key features of the U.S. market that will support a compound annual growth rate (CAGR) of 18.2% to $33.9 billion in 2025.

Emerging Adult-Use Markets (those launched between Jan. 1, 2017 and Jan. 1, 2020) were the biggest component of the market at $5.1 billion in 2019. Most are faring much better than the largest U.S. market of California: Massachusetts total revenue grew 170% in its first full year of adult-use sales while California struggled to grow sales 18% in 2019 following the launch of adult-use in January 2018.
Even Mature Adult-Use Markets (launched before 2017) can show news signs of life: Colorado cannabis revenue jumped 13% to $1.7 billion in 2019 compared to just 3% growth in 2018.
Emerging Medical Markets (launched in the last three years) also posted large gains in 2019: Pennsylvania revenue hit $420 million in its second year of sales, and Oklahoma sales increased to $365 million.
Even Mature Medical Markets (launched before 2017) can show explosive growth: Hawaii’s sales were up 90% and Puerto Rico’s 100% in 2019.
Looking ahead, 20 New Medical Markets will add $2.2 billion in spending to the market by 2025, led by Texas, Missouri and Georgia.
New Adult-Use Markets are forecast to add $8 billion in sales between 2019 and 2025, led by Florida, New York and New Jersey.

Testimonials

The Report is an exhaustively researched reference work on the universe of medical marijuana.

Steve Katz

New York State Assemblyman
94th District
The quality of content in the report shows that this group is clearly staying on the forefront of the industry.

Emily Paxhia

Managing Director
Poseidon Asset Management
The depth and breadth is unsurpassed and simply not available anywhere else.

Mark Passerini

Co-founder
Om of Medicine
The thought of investing without the depth of information it provides is tantamount to flying blind.

Steve Trenk

Managing Member
Lizada Capital

Testimonials

The Report is an exhaustively researched reference work on the universe of medical marijuana.

Steve Katz

New York State Assemblyman
94th District
The quality of content in the report shows that this group is clearly staying on the forefront of the industry.

Emily Paxhia

Managing Director
Poseidon Asset Management
The depth and breadth is unsurpassed and simply not available anywhere else.

Mark Passerini

Co-founder
Om of Medicine
The thought of investing without the depth of information it provides is tantamount to flying blind.

Steve Trenk

Managing Member
Lizada Capital

#1 Cited Source

What You’ll Find Inside

If you are an entrepreneur, investor, or regulator that will be making expensive decisions over the next year about your involvement in this industry, then you need the best information and analysis available.